Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
480.77
+6.49 (1.37%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Madrigal Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $550 → $542 | Hold | Reiterates | $550 → $542 | +12.74% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +28.96% | May 28, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $709 → $514 | Buy | Reiterates | $709 → $514 | +6.83% | May 26, 2026 |
| Barclays | Barclays | Buy Reiterates $964 | Buy | Reiterates | $964 | +100.51% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $587 → $578 | Buy | Maintains | $587 → $578 | +20.22% | May 7, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $652 → $649 | Buy | Maintains | $652 → $649 | +34.99% | May 7, 2026 |
| Clear Street | Clear Street | Buy Maintains $533 → $680 | Buy | Maintains | $533 → $680 | +41.44% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $644 | Buy | Maintains | $644 | +33.95% | May 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.